APA (7th ed.) Citation

MIJ, H., YS, H., EH, T., KAQ, C., B, v. d. W., L, I. '. V., . . . CE, T. (2026). An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration. Nature medicine, 32(6), 2083. https://doi.org/10.1038/s41591-026-04341-6

Chicago Style (17th ed.) Citation

MIJ, Honey, et al. "An Acetylated Tau-174 CSF Biomarker Discriminates Between TDP-43 and Tau Pathology in Patients with Frontotemporal Lobar Degeneration." Nature Medicine 32, no. 6 (2026): 2083. https://doi.org/10.1038/s41591-026-04341-6.

MLA (9th ed.) Citation

MIJ, Honey, et al. "An Acetylated Tau-174 CSF Biomarker Discriminates Between TDP-43 and Tau Pathology in Patients with Frontotemporal Lobar Degeneration." Nature Medicine, vol. 32, no. 6, 2026, p. 2083, https://doi.org/10.1038/s41591-026-04341-6.